Lymphoma Survivors

Lymphoma research over the past fifty years has done what the previous thousands of years of history failed to do: create lymphoma survivors. Prior to the 1960s, a diagnosis of lymphoma or leukemia was the same thing as a death sentence. Patients were typically hospitalized and given basic palliative care to keep them comfortable until they passed away. Unlike with solid tumor cancers, where surgery provided treatment options, there were no treatment options for patients with blood cancers.

This changed thanks to the tireless work of one man, Dr. Sidney Farber. He is considered the father of modern chemotherapy, and chemotherapy is credited with improving the survival rate of lymphoma and leukemia far beyond what has been accomplished in the same time frame among solid tumor cancers.

So where to find lymphoma survivors?

Fortunately, many lymphoma survivors volunteer their time to cancer societies and other groups to pass along their wisdom or to simply lend support to the people that are going through the same things they went through, and they serve as excellent beacons of hope for patients who feel hopeless.

Lymphoma survivors can be found at online support groups, in blogs, and among cancer survivor networks online such as the American Cancer Society's lymphoma-specific Cancer Survivors Network. Additionally, organizations like the Lymphoma Research Foundation can help match lymphoma patients with lymphoma survivors who share the same diagnosis.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap